1. Home
  2. CHEK vs MBIO Comparison

CHEK vs MBIO Comparison

Compare CHEK & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • MBIO
  • Stock Information
  • Founded
  • CHEK 2004
  • MBIO 2015
  • Country
  • CHEK Israel
  • MBIO United States
  • Employees
  • CHEK N/A
  • MBIO N/A
  • Industry
  • CHEK Medical Electronics
  • MBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHEK Health Care
  • MBIO Health Care
  • Exchange
  • CHEK Nasdaq
  • MBIO Nasdaq
  • Market Cap
  • CHEK 9.0M
  • MBIO 7.3M
  • IPO Year
  • CHEK 2015
  • MBIO N/A
  • Fundamental
  • Price
  • CHEK $0.93
  • MBIO $2.81
  • Analyst Decision
  • CHEK
  • MBIO Strong Buy
  • Analyst Count
  • CHEK 0
  • MBIO 1
  • Target Price
  • CHEK N/A
  • MBIO $100.00
  • AVG Volume (30 Days)
  • CHEK 88.2K
  • MBIO 411.9K
  • Earning Date
  • CHEK 02-18-2025
  • MBIO 03-10-2025
  • Dividend Yield
  • CHEK N/A
  • MBIO N/A
  • EPS Growth
  • CHEK N/A
  • MBIO N/A
  • EPS
  • CHEK N/A
  • MBIO N/A
  • Revenue
  • CHEK N/A
  • MBIO N/A
  • Revenue This Year
  • CHEK N/A
  • MBIO N/A
  • Revenue Next Year
  • CHEK N/A
  • MBIO N/A
  • P/E Ratio
  • CHEK N/A
  • MBIO N/A
  • Revenue Growth
  • CHEK N/A
  • MBIO N/A
  • 52 Week Low
  • CHEK $0.56
  • MBIO $2.71
  • 52 Week High
  • CHEK $3.45
  • MBIO $74.50
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 42.16
  • MBIO 28.00
  • Support Level
  • CHEK $0.81
  • MBIO $3.96
  • Resistance Level
  • CHEK $1.00
  • MBIO $6.70
  • Average True Range (ATR)
  • CHEK 0.10
  • MBIO 0.97
  • MACD
  • CHEK -0.05
  • MBIO -0.12
  • Stochastic Oscillator
  • CHEK 13.98
  • MBIO 2.83

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: